Skip to main content
Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1681 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2025-04-28 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 1681

About Consun Pharmaceutical Group Limited

http://www.chinaconsun.com

Consun Pharmaceutical Group Limited is a modern pharmaceutical enterprise engaged in the integrated research, development, manufacturing, and marketing of pharmaceutical products. The company's core business is segmented into Modern Chinese Medicines (MCM) and Medical Contrast Medium products. The MCM portfolio targets major therapeutic areas, including chronic renal diseases (featuring products like Uremic Clearance Granules), liver and gallbladder conditions, and orthopedic trauma. In the medical imaging field, Consun supplies contrast agents such as Gadopentetate Dimeglumine Injection for magnetic resonance imaging (MRI) and Iopamidol Injection for angiography and neuro-radiology. The enterprise focuses on combining the modernization of Chinese medicine with advanced diagnostic solutions.

Recent filings

Filing Released Lang Actions
Notification Letter to Shareholders - Annual General Meeting
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice and invitation to shareholders for the Annual General Meeting, outlining meeting date, venue, voting arrangements and online participation. It is sent to solicit votes and attendance at the AGM rather than presenting financial results or actual AGM presentation materials. This aligns with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials provided to shareholders to request votes for meetings.
2025-04-28 Chinese
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for the Annual General Meeting, which is sent to shareholders to provide information and request votes (appoint proxies) on resolutions at the AGM. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2025-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the official notice convening the Annual General Meeting, listing agenda items, resolutions, proxy instructions and meeting logistics. It is a solicitation of shareholder votes and information statement rather than the meeting materials or a post-meeting report. This matches the Proxy Solicitation & Information Statement category (Code: PSI).
2025-04-28 English
(1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED FINAL DIVIDEND, (3) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES, AND (4) NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a detailed shareholder circular containing the notice of the annual general meeting, resolutions to be voted on (re-election of directors, final dividend, general mandates for share issue and repurchase), explanatory statements, appendices with director particulars, and proxy instructions. It is not the full annual report or earnings release but rather the proxy solicitation/information statement sent to shareholders ahead of the AGM. This matches the definition of a Proxy Solicitation & Information Statement (Code: PSI).
2025-04-28 English
Voluntary Announcement Notice of Approval for Clinical Trial for SK-09 Tablet
Regulatory Filings Classification · 0% confidence The document is a voluntary corporate announcement regarding the approval of a clinical trial by a regulatory body. It does not contain financial results, corporate governance changes, shareholder voting details, or any specialized report format. It is a general regulatory announcement that does not fit any other specific category, so it defaults to Regulatory Filings (RNS).
2025-04-25 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Governance Information Classification · 1% confidence The document is a listing of the company’s board members, their designations (executive, non-executive, independent), and their roles on various Board Committees. It does not announce any specific changes in management nor is it a notice of a vote, dividend, transcript, or report publication. Instead, it describes the corporate governance structure (board composition and committee membership). This aligns with the Governance Information category.
2025-04-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.